期刊文献+

腹膜透析技术相关性并发症的研究 被引量:5

Study on Complications Associated with Peritoneal Dialysis Techniques
暂未订购
导出
摘要 目的探讨腹膜透析技术规范化的必要性及临床意义。方法选取2007年2月至2011年8月采用腹膜透析技术治疗慢性肾功能衰竭患者69例,研究与腹膜透析技术相关的并发症情况。结果与腹膜透析技术相关的并发症主要包括:感染(发生率由2007年的42.85%逐年下降至2011年的5.26%,总发生率为14.49%);外科技术相关性并发症如管周渗漏(4.35%)、渗血(15.94%)、疼痛(39.13%);导管技术相关性并发症如导管脱落(1.45%)、导管堵塞(5.80%)、导管移位(18.84%)。结论重视腹膜透析技术的规范化有助于推广腹膜透析治疗慢性肾功能衰竭,明显减少腹膜透析的退出率。 Objective To explore the necessity and clinical significance of standardized operation of peritoneal dialysis techniques. Methods Sixty-nine patients with peritoneal dialysis technology to treat chronic renal failure (CRF) from February 2007 to August 2011 were selected to analyse the complications associated with peritoneal dialysis. Results The complication of peritoneal dialysis including: infection (the incidence decreased from 42.85% in 2007 to 5.26% in 2011, with total incidence of 14.49%); the surgical technique related complications such as peritubular leak (4.35%), blood oozing (15.94%) and pain (39.13%); catheter technique related complications such as catheter shedding (1.45%), catheter obstruction (5.80%), catheter translocation (18.84%). Conclusion Payinging great attention to standardization of peritoneal dialysis techniques is helpful to promote peritoneal dialysis in the treatment of chronic renal failure, and obviously decrease the withdrawal rate of pertitoneal dialysis.
作者 曾怡 连希艳
出处 《临床医学工程》 2012年第2期212-214,共3页 Clinical Medicine & Engineering
关键词 腹膜透析 并发症 规范化技术 Pertitoneal dialysis Complications Standard technique
  • 相关文献

参考文献8

二级参考文献25

共引文献285

同被引文献42

  • 1李军,彭佑铭,周晓蓉,朱健玲,袁曙光,刘伏友.以耻骨联合上缘为腹膜透析植管体表标志探讨[J].中国医师杂志,2005,7(2):229-230. 被引量:10
  • 2刘炳岩,孙阳,徐红,周紫娟.腹膜透析相关机械并发症的诊断及处理[J].中国血液净化,2007,6(3):122-124. 被引量:7
  • 3黎伟,廖蕴华,薛超,杨桢华,黄燕林.腹膜透析相关性腹膜炎相关因素分析[J].广东医学,2007,28(8):1292-1294. 被引量:48
  • 4巫玉婷,张秀梅.血液透析并发症的防治体会[J].求医问药(下半月),2013,11(9):90.
  • 5Maroof H, Hassan Z M, Mobarez A M, et al. LactobaciUus aci- dophilus Could Modulate the Immune Response A4~alnst Breast Cancer in Murine Model[J] .J Clin Immunol, 2012, 32(6) : 1 353 - 1 359.
  • 6Ranganathan N. Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6 - month pilot scale trial in Canada[J]. Curr Med Res Opin, 2009, 25(8): 1 919 - 1 930.
  • 7Zhang S. Development of a recombinant ureolytic Lactococcus lac-tis for urea removal[J]. Artif Cells Blood Substit Immobil Biotech- nol, 2009, 37(6) ..227 - 224.
  • 8Tellez A. Characterization of immune - active peptides obtained from milk fermented by Lactobacillus helveticus[ J ]. J Dairy Res, 2010, 77(2) : 129 - 136.
  • 9Lee do K. Lactic acid bacteria affect serum cholesterol levels, harmful fecal enzyme activity, and fecal water content[J]. Lipids Health Dis. 2009.21 (8) ;21.
  • 10Popovich RP, Moncrief JW, Nolph KD,et al. Continuous ambula- tory peritoneal dialysis. Artif Organs, 1978,2 ( 1 ) :84 - 86.

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部